It was a pleasure hosting our partners and friends from abroad and Israel last week as part of the MIXiii Health-Tech.IL conference. We started off with a big partner meeting and networking event at the Maccabi Health care Services offices in Tel Aviv, where CEO Talor Sax presented updates on the strategy and activities of eHealth Ventures and Keren Shechter Azulay discussed the critical role of innovation within the Israeli healthcare system.
Later, six portfolio companies: Agamon, YonaLink, EfA Technologies, Olive Diagnostics, Nervio, and AccuLine – had the opportunity to update our partners on their recent commercial and scientific achievements.
The following day we held our annual Innovation Event. Out of 55 companies who applied, 5 finalists presented to the audience, our partners, and guests at the event. Congratulations to IdentifAI Genetics, Remepy, ToDx, NeuroHelp, and EyeContact on making it to the finals.
Many thanks to our partners who joined us in Tel Aviv and Jerusalem for making our events so special!
About eHealth Ventures
The eHealth Ventures partnership is a leading investor in early-stage digital health companies.
It includes 2 VC funds and a technological incubator with an exclusive focus on digital health and significant government non-dilutive funding. Partners include Maccabi (a leading Israeli HMO), Amgen (global biotech giant), the Mayo Clinic, Medison Ventures, Arad Investments, and the Hadar Group. The team has reviewed over 1,650 companies to date and invested in a portfolio of 24 highly innovative companies (digital diagnostics, therapeutics, home care and Bioconvergence).
